Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Computed tomography of amyloid plaques in a mouse model of Alzheimer's disease using diffraction enhanced imaging.

Connor DM, Benveniste H, Dilmanian FA, Kritzer MF, Miller LM, Zhong Z.

Neuroimage. 2009 Jul 15;46(4):908-14. doi: 10.1016/j.neuroimage.2009.03.019. Epub 2009 Mar 19.

2.

Imaging brain amyloid deposition using grating-based differential phase contrast tomography.

Pinzer BR, Cacquevel M, Modregger P, McDonald SA, Bensadoun JC, Thuering T, Aebischer P, Stampanoni M.

Neuroimage. 2012 Jul 16;61(4):1336-46. doi: 10.1016/j.neuroimage.2012.03.029. Epub 2012 Mar 16.

PMID:
22450300
3.

Quantitative analysis of amyloid plaques in a mouse model of Alzheimer's disease by phase-contrast X-ray computed tomography.

Noda-Saita K, Yoneyama A, Shitaka Y, Hirai Y, Terai K, Wu J, Takeda T, Hyodo K, Osakabe N, Yamaguchi T, Okada M.

Neuroscience. 2006;138(4):1205-13. Epub 2006 Feb 7.

PMID:
16460878
4.

Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.

Wadghiri YZ, Li J, Wang J, Hoang DM, Sun Y, Xu H, Tsui W, Li Y, Boutajangout A, Wang A, de Leon M, Wisniewski T.

PLoS One. 2013;8(2):e57097. doi: 10.1371/journal.pone.0057097. Epub 2013 Feb 27.

5.

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model.

Koronyo-Hamaoui M, Koronyo Y, Ljubimov AV, Miller CA, Ko MK, Black KL, Schwartz M, Farkas DL.

Neuroimage. 2011 Jan;54 Suppl 1:S204-17. doi: 10.1016/j.neuroimage.2010.06.020. Epub 2010 Jun 13.

6.

Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.

Poduslo JF, Wengenack TM, Curran GL, Wisniewski T, Sigurdsson EM, Macura SI, Borowski BJ, Jack CR Jr.

Neurobiol Dis. 2002 Nov;11(2):315-29.

PMID:
12505424
7.

MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice.

Meadowcroft MD, Connor JR, Smith MB, Yang QX.

J Magn Reson Imaging. 2009 May;29(5):997-1007. doi: 10.1002/jmri.21731.

8.

Magnetization transfer contrast imaging reveals amyloid pathology in Alzheimer's disease transgenic mice.

Bigot C, Vanhoutte G, Verhoye M, Van der Linden A.

Neuroimage. 2014 Feb 15;87:111-9. doi: 10.1016/j.neuroimage.2013.10.056. Epub 2013 Nov 2.

PMID:
24188815
9.

Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.

Kim JH, Ha TL, Im GH, Yang J, Seo SW, Chung JJ, Chae SY, Lee IS, Lee JH.

Neuroreport. 2014 Mar 5;25(4):211-8. doi: 10.1097/WNR.0000000000000067.

10.

Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-κB concomitantly lower Alzheimer's disease plaque formation and microglial activation in AβPP/PS-1 transgenic mouse brain.

Solberg NO, Chamberlin R, Vigil JR, Deck LM, Heidrich JE, Brown DC, Brady CI, Vander Jagt TA, Garwood M, Bisoffi M, Severns V, Vander Jagt DL, Sillerud LO.

J Alzheimers Dis. 2014;40(1):191-212. doi: 10.3233/JAD-131031.

11.

Development of novel 123I-labeled pyridyl benzofuran derivatives for SPECT imaging of β-amyloid plaques in Alzheimer's disease.

Ono M, Cheng Y, Kimura H, Watanabe H, Matsumura K, Yoshimura M, Iikuni S, Okamoto Y, Ihara M, Takahashi R, Saji H.

PLoS One. 2013 Sep 13;8(9):e74104. doi: 10.1371/journal.pone.0074104. eCollection 2013.

12.

In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.

Jack CR Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF.

J Neurosci. 2005 Oct 26;25(43):10041-8.

13.

Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.

Zhang J, Yarowsky P, Gordon MN, Di Carlo G, Munireddy S, van Zijl PC, Mori S.

Magn Reson Med. 2004 Mar;51(3):452-7.

14.
15.

Intraneuronal Aβ accumulation, amyloid plaques, and synapse pathology in Alzheimer's disease.

Capetillo-Zarate E, Gracia L, Tampellini D, Gouras GK.

Neurodegener Dis. 2012;10(1-4):56-9. doi: 10.1159/000334762. Epub 2012 Jan 21.

PMID:
22269167
16.

Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease.

Schmitz C, Rutten BP, Pielen A, Schäfer S, Wirths O, Tremp G, Czech C, Blanchard V, Multhaup G, Rezaie P, Korr H, Steinbusch HW, Pradier L, Bayer TA.

Am J Pathol. 2004 Apr;164(4):1495-502.

17.

Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain.

Wengenack TM, Reyes DA, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Gilles EJ, Chamberlain R, Marjanska M, Jack CR Jr, Garwood M, Poduslo JF.

Neuroimage. 2011 Jan 1;54(1):113-22. doi: 10.1016/j.neuroimage.2010.08.033. Epub 2010 Aug 20.

18.
19.

Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.

Jack CR Jr, Marjanska M, Wengenack TM, Reyes DA, Curran GL, Lin J, Preboske GM, Poduslo JF, Garwood M.

Neuroscientist. 2007 Feb;13(1):38-48. Review.

PMID:
17229974
20.

Targeting the amyloid-β antibody in the brain tissue of a mouse model of Alzheimer's disease.

McLean D, Cooke MJ, Wang Y, Fraser P, St George-Hyslop P, Shoichet MS.

J Control Release. 2012 Apr 30;159(2):302-8. doi: 10.1016/j.jconrel.2011.12.036. Epub 2011 Dec 30.

PMID:
22245684
Items per page

Supplemental Content

Write to the Help Desk